118
Participants
Start Date
November 16, 2020
Primary Completion Date
May 23, 2024
Study Completion Date
May 23, 2024
Spironolactone
After randomization, this group will receive 12.5 mg of spironolactone daily. Subjects who did not reach the target blood pressure after 4 weeks of treatment should be increased to 25 mg of spironolactone. After 12 weeks of treatment, study will be end.
Amiloride
After randomization, this group will receive 5 mg of amiloride daily. Subjects who did not reach the target blood pressure after 4 weeks of treatment should be increased to 10 mg of amiloride. After 12 weeks of treatment, study will be end.
Severance Cardiovascular Hospital, Yonsei University Health System, Seoul
Yonsei University
OTHER